Annual Gross Profit
$2.93 M
-$5.54 M-65.40%
01 December 2023
Summary:
COSCIENS Biopharma annual gross profit is currently $2.93 million, with the most recent change of -$5.54 million (-65.40%) on 01 December 2023. During the last 3 years, it has fallen by -$5.42 million (-64.91%).CSCI Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$957.00 K
+$138.00 K+16.85%
01 September 2024
Summary:
COSCIENS Biopharma quarterly gross profit is currently $957.00 thousand, with the most recent change of +$138.00 thousand (+16.85%) on 01 September 2024. Over the past year, it has increased by +$764.80 thousand (+397.92%).CSCI Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$2.87 M
+$152.00 K+5.59%
01 September 2024
Summary:
COSCIENS Biopharma TTM gross profit is currently $2.87 million, with the most recent change of +$152.00 thousand (+5.59%) on 01 September 2024. Over the past year, it has dropped by -$111.50 thousand (-3.74%).CSCI TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Gross Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +397.9% | -3.7% |
3 y3 years | -64.9% | -53.5% | -65.4% |
5 y5 years | -28.6% | -24.9% | -31.2% |
CSCI Gross Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | -65.4% | -67.8% | -72.2% |
COSCIENS Biopharma Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $957.00 K(+16.8%) | $2.87 M(+5.6%) |
June 2024 | - | $819.00 K(-9.2%) | $2.72 M(+0.8%) |
Mar 2024 | - | $901.70 K(+369.1%) | $2.70 M(-9.6%) |
Dec 2023 | $2.93 M(-65.4%) | $192.20 K(-76.1%) | $2.98 M(-20.1%) |
Sept 2023 | - | $805.00 K(+1.0%) | $3.73 M(-18.7%) |
June 2023 | - | $797.00 K(-32.9%) | $4.59 M(-32.1%) |
Mar 2023 | - | $1.19 M(+26.0%) | $6.76 M(-20.9%) |
Dec 2022 | $8.47 M(+1.4%) | $942.00 K(-43.3%) | $8.55 M(-11.6%) |
Sept 2022 | - | $1.66 M(-44.0%) | $9.67 M(-6.3%) |
June 2022 | - | $2.97 M(-0.2%) | $10.32 M(+8.9%) |
Mar 2022 | - | $2.98 M(+44.5%) | $9.47 M(+14.3%) |
Dec 2021 | $8.35 M(+46.8%) | $2.06 M(-11.0%) | $8.29 M(+14.1%) |
Sept 2021 | - | $2.31 M(+8.7%) | $7.26 M(+17.3%) |
June 2021 | - | $2.13 M(+19.0%) | $6.19 M(+3.9%) |
Mar 2021 | - | $1.79 M(+73.4%) | $5.96 M(+2.0%) |
Dec 2020 | $5.69 M(+38.7%) | $1.03 M(-16.9%) | $5.84 M(-4.0%) |
Sept 2020 | - | $1.24 M(-34.5%) | $6.08 M(+8.5%) |
June 2020 | - | $1.89 M(+13.2%) | $5.61 M(+16.2%) |
Mar 2020 | - | $1.67 M(+31.3%) | $4.83 M(+15.7%) |
Dec 2019 | $4.10 M(-13.4%) | $1.27 M(+66.5%) | $4.17 M(-7.8%) |
Sept 2019 | - | $765.50 K(-31.2%) | $4.52 M(-1.3%) |
June 2019 | - | $1.11 M(+9.6%) | $4.58 M(-1.5%) |
Mar 2019 | - | $1.02 M(-37.5%) | $4.65 M(+3.6%) |
Dec 2018 | $4.74 M(-15.6%) | $1.63 M(+96.9%) | $4.49 M(+8.7%) |
Sept 2018 | - | $825.70 K(-30.1%) | $4.13 M(-14.2%) |
June 2018 | - | $1.18 M(+38.5%) | $4.81 M(-7.1%) |
Mar 2018 | - | $852.80 K(-32.7%) | $5.18 M(-7.7%) |
Dec 2017 | $5.61 M(-20.6%) | $1.27 M(-16.1%) | $5.61 M(+3.6%) |
Sept 2017 | - | $1.51 M(-2.7%) | $5.42 M(+1.3%) |
June 2017 | - | $1.55 M(+20.9%) | $5.35 M(-12.7%) |
Mar 2017 | - | $1.28 M(+19.9%) | $6.12 M(-12.8%) |
Dec 2016 | $7.06 M(+28.3%) | $1.07 M(-25.7%) | $7.02 M(-9.0%) |
Sept 2016 | - | $1.44 M(-38.2%) | $7.72 M(+0.5%) |
June 2016 | - | $2.33 M(+6.7%) | $7.68 M(+13.6%) |
Mar 2016 | - | $2.18 M(+23.4%) | $6.76 M(+29.9%) |
Dec 2015 | $5.51 M(+27.6%) | $1.77 M(+26.1%) | $5.21 M(+30.9%) |
Sept 2015 | - | $1.40 M(-0.4%) | $3.98 M(+2.1%) |
June 2015 | - | $1.41 M(+125.5%) | $3.89 M(+1.4%) |
Mar 2015 | - | $624.80 K(+15.9%) | $3.84 M(-8.0%) |
Dec 2014 | $4.32 M(+43.4%) | $539.10 K(-59.2%) | $4.17 M(+0.6%) |
Sept 2014 | - | $1.32 M(-2.4%) | $4.15 M(+13.9%) |
June 2014 | - | $1.35 M(+41.1%) | $3.64 M(+28.3%) |
Mar 2014 | - | $959.00 K(+86.2%) | $2.84 M(-2.5%) |
Dec 2013 | $3.01 M(+22.9%) | $515.10 K(-36.9%) | $2.91 M(+3.6%) |
Sept 2013 | - | $816.10 K(+48.3%) | $2.81 M(+4.9%) |
June 2013 | - | $550.40 K(-46.7%) | $2.68 M(-4.0%) |
Mar 2013 | - | $1.03 M(+149.6%) | $2.79 M(+14.9%) |
Dec 2012 | $2.45 M(-25.4%) | $413.50 K(-39.6%) | $2.43 M(-17.7%) |
Sept 2012 | - | $684.70 K(+3.5%) | $2.95 M(+2.8%) |
June 2012 | - | $661.60 K(-1.3%) | $2.87 M(-4.8%) |
Mar 2012 | - | $670.40 K(-28.3%) | $3.02 M(-8.4%) |
Dec 2011 | $3.28 M | $935.30 K(+54.4%) | $3.29 M(+1.3%) |
Sept 2011 | - | $605.60 K(-24.9%) | $3.25 M(-3.5%) |
June 2011 | - | $806.00 K(-15.0%) | $3.37 M(+12.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2011 | - | $948.00 K(+6.0%) | $3.00 M(+19.6%) |
Dec 2010 | $2.44 M(+30.8%) | $894.10 K(+23.6%) | $2.51 M(+52.3%) |
Sept 2010 | - | $723.10 K(+64.8%) | $1.65 M(+17.3%) |
June 2010 | - | $438.90 K(-3.8%) | $1.41 M(-13.5%) |
Mar 2010 | - | $456.00 K(+1343.0%) | $1.63 M(-11.8%) |
Dec 2009 | $1.86 M(+54.0%) | $31.60 K(-93.4%) | $1.85 M(+6.2%) |
Sept 2009 | - | $480.10 K(-27.2%) | $1.74 M(+15.3%) |
June 2009 | - | $659.20 K(-2.2%) | $1.51 M(+11.8%) |
Mar 2009 | - | $674.30 K(-987.2%) | $1.35 M(+41.5%) |
Dec 2008 | $1.21 M(-21.7%) | -$76.00 K(-130.4%) | $953.00 K(-27.7%) |
Sept 2008 | - | $250.10 K(-49.9%) | $1.32 M(+3.7%) |
June 2008 | - | $499.70 K(+79.0%) | $1.27 M(-5.9%) |
Mar 2008 | - | $279.20 K(-3.5%) | $1.35 M(-12.8%) |
Dec 2007 | $1.55 M(+11.1%) | $289.40 K(+42.4%) | $1.55 M(+22.1%) |
Sept 2007 | - | $203.30 K(-64.9%) | $1.27 M(-12.4%) |
June 2007 | - | $579.90 K(+21.3%) | $1.45 M(+2.1%) |
Mar 2007 | - | $478.10 K(+5524.7%) | $1.42 M(+6.1%) |
Dec 2006 | $1.39 M(+8.1%) | $8500.00(-97.8%) | $1.34 M(-18.5%) |
Sept 2006 | - | $383.00 K(-30.4%) | $1.64 M(+1.5%) |
June 2006 | - | $550.50 K(+38.9%) | $1.62 M(+3.0%) |
Mar 2006 | - | $396.40 K(+26.6%) | $1.57 M(+19.9%) |
Dec 2005 | $1.29 M(+79.1%) | $313.00 K(-12.8%) | $1.31 M(+16.6%) |
Sept 2005 | - | $359.10 K(-28.6%) | $1.12 M(+30.0%) |
June 2005 | - | $502.80 K(+270.3%) | $864.50 K(+35.2%) |
Mar 2005 | - | $135.80 K(+7.7%) | $639.30 K(-14.9%) |
Dec 2004 | $719.20 K(-22.1%) | $126.10 K(+26.4%) | $751.50 K(-21.0%) |
Sept 2004 | - | $99.80 K(-64.0%) | $950.70 K(-10.8%) |
June 2004 | - | $277.60 K(+11.9%) | $1.07 M(-4.4%) |
Mar 2004 | - | $248.00 K(-23.8%) | $1.11 M(+13.1%) |
Dec 2003 | $923.00 K(+91.1%) | $325.30 K(+51.2%) | $985.90 K(+43.3%) |
Sept 2003 | - | $215.20 K(-34.0%) | $688.00 K(+12.3%) |
June 2003 | - | $326.10 K(+173.3%) | $612.90 K(+8.2%) |
Mar 2003 | - | $119.30 K(+335.4%) | $566.50 K(+14.7%) |
Dec 2002 | $483.10 K(+77.6%) | $27.40 K(-80.4%) | $493.80 K(-0.2%) |
Sept 2002 | - | $140.10 K(-49.9%) | $494.70 K(+3.5%) |
June 2002 | - | $279.70 K(+500.2%) | $478.10 K(+74.5%) |
Mar 2002 | - | $46.60 K(+64.7%) | $274.00 K(+2.4%) |
Dec 2001 | $272.00 K(+38.7%) | $28.30 K(-77.1%) | $267.50 K(+40.4%) |
Sept 2001 | - | $123.50 K(+63.4%) | $190.50 K(-21.7%) |
June 2001 | - | $75.60 K(+88.5%) | $243.30 K(+3.4%) |
Mar 2001 | - | $40.10 K(-182.3%) | $235.20 K(+20.6%) |
Dec 2000 | $196.10 K(+130.4%) | -$48.70 K(-127.6%) | $195.10 K(+0.1%) |
Sept 2000 | - | $176.30 K(+161.2%) | $195.00 K(+25.9%) |
June 2000 | - | $67.50 K(>+9900.0%) | $154.90 K(+77.2%) |
Mar 2000 | - | $0.00(-100.0%) | $87.40 K(0.0%) |
Dec 1999 | $85.10 K(-58.0%) | -$48.80 K(-135.8%) | $87.40 K(-35.1%) |
Sept 1999 | - | $136.20 K(-8612.5%) | $134.60 K(-33.6%) |
Dec 1998 | $202.50 K(-29.9%) | -$1600.00(-100.8%) | $202.60 K(-50.7%) |
June 1998 | - | $204.20 K(+51.6%) | $411.30 K(+16.8%) |
Dec 1997 | $289.00 K(+294.3%) | $134.70 K(+86.0%) | $352.00 K(+62.0%) |
Sept 1997 | - | $72.40 K(0.0%) | $217.30 K(+50.0%) |
June 1997 | - | $72.40 K(-0.1%) | $144.90 K(+99.9%) |
Mar 1997 | - | $72.50 K | $72.50 K |
Dec 1996 | $73.30 K | - | - |
FAQ
- What is COSCIENS Biopharma annual gross profit?
- What is the all time high annual gross profit for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly gross profit?
- What is the all time high quarterly gross profit for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly gross profit year-on-year change?
- What is COSCIENS Biopharma TTM gross profit?
- What is the all time high TTM gross profit for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM gross profit year-on-year change?
What is COSCIENS Biopharma annual gross profit?
The current annual gross profit of CSCI is $2.93 M
What is the all time high annual gross profit for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual gross profit is $8.47 M
What is COSCIENS Biopharma quarterly gross profit?
The current quarterly gross profit of CSCI is $957.00 K
What is the all time high quarterly gross profit for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly gross profit is $2.98 M
What is COSCIENS Biopharma quarterly gross profit year-on-year change?
Over the past year, CSCI quarterly gross profit has changed by +$764.80 K (+397.92%)
What is COSCIENS Biopharma TTM gross profit?
The current TTM gross profit of CSCI is $2.87 M
What is the all time high TTM gross profit for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM gross profit is $10.32 M
What is COSCIENS Biopharma TTM gross profit year-on-year change?
Over the past year, CSCI TTM gross profit has changed by -$111.50 K (-3.74%)